Los puntos clave no están disponibles para este artículo en este momento.
A ligands are the first example of a ubiquitin-free strategy for targeted protein degradation.
Shi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: